Scalp Care Efficacy Evaluation for Premium Revitalizing Elixir
NCT07271212
Alopecia, Hair Condition
Taichung, Taiwan
View Trial DetailsNCT Number: NCT07716748
This study is to evaluate differences in the gut and follicle/scalp microbiome signature in AGA compared to a non-AGA population. Also, to investigate differences in inflammation and other biomarkers in AGA compared to non-AGA population at baseline and after a successful treatment
Trial opening soon.
Get Notified21 year–45 year
Male
Observational
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Volunteers in the healthy control panel must satisfy the following criteria:
Volunteers in the AGA panel must satisfy the following criteria:
Exclusion criteria
Non-inclusion Criteria:
Time frame: 6 months
Scale from 1 (no hair loss) to 7 (severe hair loss)
Time frame: 6 months
Change from baseline in hair density at the vertex, crown and occipital zones Unit: u/cm2
Time frame: 6 months
Change in concentration of metabolites in the stool of AGA vs healthy cohorts.
Time frame: Baseline
Taxonomic and functional composition of the gut and scalp/hair follicle microbiome.
Units: relative abundance
Time frame: 6 months
Change in protein expression levels in scalp swabs samples, and differences between AGA and healthy cohorts.
Time frame: 6 months
Evaluation of differentially expressed genes via spatial transcriptomics and single-cell RNA sequencing (scRNA-seq) from scalp biopsy samples comparing AGA participants to healthy controls.
Units: Log2 Fold Change (or "Normalized Gene Expression Counts")
Time frame: 6 months
Change in concentration of metabolites in blood/plasma
Time frame: 6 months
Change in proteins concentration levels in blood/plasma
Time frame: 6 months
Change from baseline in hair shaft diameter. Unit: µm
Time frame: 6 months
The distance from the eyebrow to the hairline is one indicator of the recession of hairline
Time frame: 6 months
The dandruff score ranges from 0 (no dandruff state) to 5 (very important dandruff state) for both adherent and non-adherent dandruffs
Time frame: 6 months
Evaluation of the volunteer's perceived change in hair density since the start of the study (assessed via self-assessment questionnaire).
Scale : improvements range from "worsened significantly" to "improved significantly"
Time frame: 6 months
Measure sebum levels on the forehead and scalp
Time frame: 6 months
Association between gut microbiome composition (metabolomics and metagenomics from stool and blood/plasma) and clinical response to oral minoxidil treatment.
Time frame: 6 months
Change from baseline in percentage of single, double, triple... follicular units.
National Skin Centre
Network
Beyond the Scalp: A Multi-Omic Microbiome Analysis in Androgenetic Alopecia Patients at Baseline and After Oral Minoxidil Treatment Versus Healthy Controls
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07271212
Alopecia, Hair Condition
Taichung, Taiwan
View Trial DetailsNCT07228156
Alopecia, Hair Diseases
Maitland, Florida, United States
View Trial DetailsNCT05502796
Alopecia, Autoimmune Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT07615608
Alopecia, Androgenetic Alopecia
Barcelona, Spain
View Trial Details